Please select the option that best describes you:

How does neoadjuvant chemo-immunotherapy impact your decision on hypofractionation/dose-fractionation for locally advance NSCLC now getting RT alone?   

Is 60 Gy/15 fx appropriate? Is there a volume PTV cut-off cc which would switch to a more fractionated approach (60 Gy/30 fx eg)? Is there an area you would dose reduce (e.g., hilum or mediastinum) after neoadj chemo-immunotx?



Answer from: Radiation Oncologist at Academic Institution
Sign in or Register to read more